We are live on ! Find out more

523 hedge funds and large institutions have $8.37B invested in Labcorp in 2014 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 165 increasing their positions, 229 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more call options, than puts

Call options by funds: $156M | Put options by funds: $86.6M

5% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 43

0% more capital invested

Capital invested by funds: $8.34B → $8.37B (+$33.3M)

1% less funds holding

Funds holding: 526523 (-3)

3.78% less ownership

Funds ownership: 115.96%112.18% (-3.8%)

28% less repeat investments, than reductions

Existing positions increased: 165 | Existing positions reduced: 229

33% less funds holding in top 10

Funds holding in top 10: 96 (-3)

Holders
523
Holders Change
-3
Holders Change %
-0.57%
% of All Funds
15.03%
Holding in Top 10
6
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-33.33%
% of All Funds
0.17%
New
45
Increased
165
Reduced
229
Closed
43
Calls
$156M
Puts
$86.6M
Net Calls
+$69.6M
Net Calls Change
+$120M

LH Hedge Fund Activity: Q2 2014 in Review

523 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q2 2014, worth a combined $8.37B — up 0.4% from $8.34B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new LH positions and 43 closed out — a net gain of 2 holders — while 165 added to existing stakes and 229 trimmed.

The largest buyer was Boston Partners, adding an estimated $210M. The largest seller was Davis Selected Advisers, cutting an estimated $291M.

  • 523 institutional investors held Labcorp (LH) as of Q2 2014, down from 526 in Q1 2014.
  • Funds reported $8.37B of Labcorp stock for Q2 2014, up 0.4% quarter-over-quarter.
  • 45 funds opened new Labcorp positions in Q2 2014 and 43 closed out, a net change of +2 holders.
  • The largest Labcorp buyer in Q2 2014 was Boston Partners, an estimated $210M added.
  • The largest Labcorp seller in Q2 2014 was Davis Selected Advisers, an estimated $291M sold.

Based on aggregated 13F filings for Q2 2014.